{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:01:20Z","timestamp":1794852080388,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029267"],"award-info":[{"award-number":["R01AA029267"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA035772"],"award-info":[{"award-number":["P30DA035772"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ajpm-online.net","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.amepre.2024.11.006","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:46:59Z","timestamp":1732812419000},"page":"446-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-0538","authenticated-orcid":false,"given":"Alene","family":"Kennedy-Hendricks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1828-9098","authenticated-orcid":false,"given":"Alisa B.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hocine","family":"Azeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance M.","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Uscher-Pines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Hodgkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiden A.","family":"Huskamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2024.11.006_bib0001","series-title":"Deaths from Excessive Alcohol Use in the United States [Internet]","year":"2024"},{"issue":"6","key":"10.1016\/j.amepre.2024.11.006_bib0002","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/acer.14609","article-title":"A cascade of care for alcohol use disorder: Using 2015\u20132019 national survey on drug use and health data to identify gaps in past 12-month care","volume":"45","author":"Mintz","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.amepre.2024.11.006_bib0003","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2022 national survey on drug use and health. HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 5600 Fishers Lane, Rockville, MD 20857. https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-annual-national-report."},{"issue":"8","key":"10.1016\/j.amepre.2024.11.006_bib0004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamapsychiatry.2021.1271","article-title":"Use of medications for alcohol use disorder in the US: results from the 2019 national survey on drug use and health","volume":"78","author":"Han","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"17","key":"10.1016\/j.amepre.2024.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.2023.19761","article-title":"Pharmacotherapy for alcohol use disorder: a systematic review and meta-analysis","volume":"330","author":"McPheeters","year":"2023","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2024.11.006_bib0006","doi-asserted-by":"crossref","first-page":"e87366","DOI":"10.1371\/journal.pone.0087366","article-title":"Disulfiram efficacy in the treatment of alcohol dependence: a meta-analysis","volume":"9","author":"Skinner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.amepre.2024.11.006_bib0007","article-title":"VA\/DoD clinical practice guideline for the management of substance use disorders version 4.0","year":"2021","journal-title":"VA Clin. Pract. Guidel"},{"issue":"1","key":"10.1016\/j.amepre.2024.11.006_bib0008","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","article-title":"The American psychiatric association practice guideline for the pharmacologic treatment of patients with alcohol use disorder","volume":"175","author":"Reus","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.amepre.2024.11.006_bib0009","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1176\/ps.2010.61.4.392","article-title":"Pharmacotherapy of alcohol use disorders in the Veterans health administration","volume":"61","author":"Harris","year":"2010","journal-title":"Psychiatr Serv"},{"issue":"1","key":"10.1016\/j.amepre.2024.11.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-016-0063-8","article-title":"Multifaceted academic detailing program to increase pharmacotherapy for alcohol use disorder: interrupted time series evaluation of effectiveness","volume":"11","author":"Harris","year":"2016","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.amepre.2024.11.006_bib0011","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpsychires.2015.07.016","article-title":"Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. veterans health administration patients with dual diagnoses","volume":"69","author":"Rubinsky","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.amepre.2024.11.006_bib0012","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jsat.2018.08.002","article-title":"Access to treatment for alcohol use disorders following Oregon's health care reforms and Medicaid expansion","volume":"94","author":"McCarty","year":"2018","journal-title":"J Subst Abus Treat"},{"issue":"1","key":"10.1016\/j.amepre.2024.11.006_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13722-019-0147-3","article-title":"Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"11","key":"10.1016\/j.amepre.2024.11.006_bib0014","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s11606-020-06073-w","article-title":"Medication utilization for alcohol use disorder in a commercially insured population","volume":"35","author":"Huskamp","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.11.006_bib0015","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1097\/ADM.0000000000000918","article-title":"First-line medications for the outpatient treatment of alcohol use disorder: a systematic review of perceived barriers","volume":"16","author":"Gregory","year":"2022","journal-title":"J Addict Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.11.006_bib0016","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1370\/afm.2997","article-title":"Prescribing medications for alcohol use disorder: a qualitative study of primary care physician decision making","volume":"21","author":"Bhardwaj","year":"2023","journal-title":"Ann Fam Med"},{"issue":"NOV","key":"10.1016\/j.amepre.2024.11.006_bib0017","first-page":"1","article-title":"Pharmacotherapy for alcohol use disorders: physicians\u2019 perceptions and practices","volume":"7","author":"Martinez","year":"2016","journal-title":"Front Psychiatry"},{"issue":"7","key":"10.1016\/j.amepre.2024.11.006_bib0018","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s11606-020-06454-1","article-title":"Characterizing the variation of alcohol cessation pharmacotherapy in primary care","volume":"36","author":"Bernstein","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2024.11.006_bib0019","first-page":"1","article-title":"Medications for alcohol use disorder: rates and predictors of prescription order and fill in outpatient settings","author":"Hodgkin","year":"2024","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2024.11.006_bib0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/hec.1737","article-title":"Customization in prescribing for bipolar disorder","volume":"21","author":"Hodgkin","year":"2012","journal-title":"Heal Econ"},{"issue":"6","key":"10.1016\/j.amepre.2024.11.006_bib0021","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jhealeco.2007.08.002","article-title":"Custom-made versus ready-to-wear treatments: behavioral propensities in physicians\u2019 choices","volume":"26","author":"Frank","year":"2007","journal-title":"J Health Econ"},{"key":"10.1016\/j.amepre.2024.11.006_bib0022","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s12325-020-01605-6","article-title":"Body mass index variable interpolation to expand the utility of real-world administrative healthcare claims database analyses","volume":"38","author":"Wu","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.amepre.2024.11.006_bib0023","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2147\/CLEP.S355086","article-title":"Development and validation of algorithms to identify COVID-19 patients using a us electronic health records database: a retrospective cohort study","volume":"14","author":"Brown","year":"2022","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.amepre.2024.11.006_bib0024","first-page":"269","article-title":"Association between elevated blood eosinophils and chronic kidney disease progression: analyses of a large United States electronic health records database","author":"Kielar","year":"2023","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.amepre.2024.11.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108540","article-title":"Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder","volume":"133","author":"Morgan","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.amepre.2024.11.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.19651","article-title":"Comparison of Substance use disorder diagnosis rates from electronic health record data with substance use disorder prevalence rates reported in surveys across sociodemographic groups in the veterans health administration","volume":"5","author":"Williams","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"April 2019","key":"10.1016\/j.amepre.2024.11.006_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.11.008","article-title":"Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network","volume":"110","author":"Hallgren","year":"2020","journal-title":"J Subst Abuse Treat [Internet]"},{"issue":"7","key":"10.1016\/j.amepre.2024.11.006_bib0028","article-title":"Characteristics and prescribing patterns of clinicians waivered to prescribe buprenorphine for opioid use disorder before and after release of new practice guidelines","volume":"4","author":"Jones","year":"2023","journal-title":"JAMA Heal Forum"},{"issue":"21","key":"10.1016\/j.amepre.2024.11.006_bib0029","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1001\/jama.2021.4469","article-title":"Concentration of patient care among buprenorphine-prescribing clinicians in the US","volume":"325","author":"Stein","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2024.11.006_bib0030","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/M19-3975","article-title":"Medication for opioid use disorder: a national survey of primary care physicians","volume":"173","author":"McGinty","year":"2020","journal-title":"Ann Intern Med"},{"issue":"Aug 6","key":"10.1016\/j.amepre.2024.11.006_bib0031","article-title":"Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians","volume":"216","author":"Kennedy-Hendricks","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.amepre.2024.11.006_bib0032","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/alcalc\/agv127","article-title":"Alcohol use disorders in primary health care: what do we know and where do we go?","volume":"51","author":"Rehm","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.amepre.2024.11.006_bib0033","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11606-022-07707-x","article-title":"Revisiting the time needed to provide adult primary care","volume":"38","author":"Porter","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10.1016\/j.amepre.2024.11.006_bib0034","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1215\/03616878-3620821","article-title":"The rise of primary care physicians in the provision of US mental health care","volume":"41","author":"Olfson","year":"2016","journal-title":"J Health Polit Policy Law"},{"issue":"7","key":"10.1016\/j.amepre.2024.11.006_bib0035","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s11606-021-07260-z","article-title":"Does primary care fill the gap in access to specialty mental health care? A mixed methods study","volume":"37","author":"Kyanko KA","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2024.11.006_bib0036","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1377\/hlthaff.2018.05145","article-title":"Trends in buprenorphine prescribing by physician specialty","volume":"38","author":"Wen","year":"2019","journal-title":"Health Aff"},{"issue":"12","key":"10.1016\/j.amepre.2024.11.006_bib0037","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1377\/hlthaff.2019.00859","article-title":"In rural areas, buprenorphine waiver adoption since 2017 driven by nurse practitioners and physician assistants","volume":"38","author":"Barnett","year":"2019","journal-title":"Heal Aff"},{"key":"10.1016\/j.amepre.2024.11.006_bib0038","unstructured":"Laschober R, Kelley L, Sartor Z, Johnson S, Griggs J. Waco guide to psychopharmacology in primary care. 2022; https:\/\/wacoguide.org. Accessed July 01, 2024."},{"key":"10.1016\/j.amepre.2024.11.006_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2020.00047","article-title":"Survey of addiction specialists\u2019 use of medications to treat alcohol use disorder","volume":"11","author":"Ehrie","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.amepre.2024.11.006_bib0040","series-title":"Interventions for Addiction: Comprehensive Addictive Behaviors and Disorders, Vol. 3","article-title":"Disulfiram for alcohol and other drug use","author":"Kerfoot","year":"2013"},{"issue":"1","key":"10.1016\/j.amepre.2024.11.006_bib0041","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/alcalc\/agaa096","article-title":"Disulfiram ethanol reaction with alcohol-based hand sanitizer: an exploratory study","volume":"56","author":"Ghosh","year":"2021","journal-title":"Alcohol Alcohol"},{"issue":"12","key":"10.1016\/j.amepre.2024.11.006_bib0042","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1176\/appi.ps.202000816","article-title":"Use of electronic health information technology in a national sample of hospitals that provide specialty substance use care","volume":"72","author":"Shields","year":"2021","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.amepre.2024.11.006_bib0043","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJMp1800465","article-title":"Improving adoption of EHRs in psychiatric care","volume":"378","author":"Busch","year":"2018","journal-title":"NEJM"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724004021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379724004021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T03:27:32Z","timestamp":1740367652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379724004021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0749379724004021"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2024.11.006","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinician Prescribing Practices Involving Medications for Alcohol Use Disorder","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2024.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}